randomized, double-blinded, placebo-controlled
REC611-IIT-1
Phase 1 mab active
Quick answer
randomized, double-blinded, placebo-controlled for Prevention of COVID-19 Caused by SARS-CoV-2 is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Prevention of COVID-19 Caused by SARS-CoV-2
- Phase
- Phase 1
- Modality
- mab
- Status
- active